Dana-Farber professor receives William Dameshek Prize for multiple myeloma research
Irene Ghobrial, MD, will receive the William Dameshek Prize at this year’s ASH Annual Meeting & Exposition.
The award is presented to an early- or mid-career hematologist who made a recent outstanding contribution to the hematology field.
Ghobrial, director of the clinical investigator research program and Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School, is being recognized for her work on the mechanisms underlying disease progression in multiple myeloma.
“Through her work, she has challenged standard myeloma patient care by leading screening for early detection of the disease, uncovering novel biomarkers for risk stratification and disrupting the traditional myeloma treatment paradigm with innovative trials in smoldering myeloma,” an ASH press release read.
Ghobrial also led PROMISE, the first screening study for high-risk individuals in the United States to detect monoclonal gammopathy of unknown significance/smoldering multiple myeloma.